Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations

v3.26.3
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Revenue:        
Total revenue $ 12,075 $ 8,861 $ 35,083 $ 26,561
Cost of revenue 5,016 3,261 13,558 10,273
Gross profit 7,059 5,600 21,525 16,288
Research and development costs 4,018 3,452 13,172 10,660
Sales and marketing expenses 5,532 3,838 19,015 11,691
General and administrative expenses 3,841 3,586 14,392 11,056
Operating loss (6,332) (5,276) (25,054) (17,119)
Other income (expense):        
Other income (expense), net 22 (64) (20) (112)
Interest income 292 396 932 832
Interest expense (1,446) (939) (4,241) (1,304)
Net loss before income taxes (7,464) (5,883) (28,383) (17,703)
Income tax (benefit) expense (4) 8 (34) 51
Net loss $ (7,460) $ (5,891) $ (28,349) $ (17,754)
Net loss per share attributable to common stockholders:        
Basic (in dollars per share) $ (0.24) $ (0.21) $ (0.94) $ (0.63)
Diluted (in dollars per share) $ (0.24) $ (0.21) $ (0.94) $ (0.63)
Weighted average shares outstanding:        
Basic (in shares) 30,983,193 28,427,574 30,237,502 28,137,528
Diluted (in shares) 30,983,193 28,427,574 30,237,502 28,137,528
Product revenue        
Revenue:        
Total revenue $ 7,891 $ 5,361 $ 24,069 $ 16,649
Service and other revenue        
Revenue:        
Total revenue $ 4,184 $ 3,500 $ 11,014 $ 9,912